Royal Bank of Canada’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-82,900
Closed -$4.27M 7753
2021
Q4
$4.27M Buy
82,900
+11,300
+16% +$554K ﹤0.01% 2501
2021
Q3
$3.54M Buy
+71,600
New +$3.88M ﹤0.01% 2591
2021
Q1
Sell
-51,700
Closed -$2.77M 7434
2020
Q4
$2.77M Hold
51,700
﹤0.01% 2635
2020
Q3
$2.43M Buy
+51,700
New +$2.65M ﹤0.01% 2528
2015
Q4
Sell
-220,000
Closed -$16.9M 6639
2015
Q3
$16.9M Buy
220,000
+181,000
+464% +$15.1M 0.01% 852
2015
Q2
$3.26M Buy
+39,000
New +$3.44M ﹤0.01% 1901

Other funds holding CAH

Royal Bank of Canada's CAH Position: Q1 2026 in Review

Royal Bank of Canada increased its Cardinal Health (CAH) stake by 35% in Q1 2026, buying an estimated $52.8M and bringing the position to 952,686 shares worth $201M. The position accounts for 0.04% of the portfolio, ranked #402.

Royal Bank of Canada first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. 1,431 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Royal Bank of Canada held 952,686 shares of Cardinal Health worth $201M as of Q1 2026.
  • Royal Bank of Canada bought 245,376 Cardinal Health shares in Q1 2026, an estimated $52.8M.
  • Cardinal Health made up 0.04% of Royal Bank of Canada's portfolio in Q1 2026, its #402 holding.
  • Royal Bank of Canada first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • 1,431 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.